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Abstract 
Around half of the mammalian genomes are composed of repetitive elements, of which most are 
transposable elements (TEs). Although certain TEs or “jumping genes” are still actively 
mobilized in the mammalian genome, their impact on gene expression remains largely unknown. 
We have focused on two genes, Slc15a2 in mice and MCC in humans, both of which have been 
linked recently to TE-mediated gene disruption. This research seeks to study the mechanisms by 
which such endogenous TE polymorphisms can result in transcriptional disruption. In the case of 
Slc15a2, we previously reported that a polymorphic endogenous retrovirus (ERV) in intron 7 
results in a 13-fold increase of a 1.2 kb prematurely-truncated transcript and a 39-fold decrease 
in the full-length, 4 kb transcript. This transcriptional disruption further resulted in a 3- to 9- fold 
down-regulation of the protein, PEPT2. We have also characterized antisense transcripts that 
were initiated from the bidirectional promoter at the 5’ end of the ERV.  In this study, we 
hypothesized that variable epigenetic regulation at the 5’ long terminal repeat (LTR) of the ERV 
could be associated with differential antisense transcription, which in turn, could affect variable 
expression of Slc15a2. To demonstrate this, we used bisulfite sequencing to assess cytosine 
methylation levels at the ERV, demonstrating a correlation between decreased local DNA 
methylation and an increase in truncated transcripts at Slc15a2.  In the case of human MCC, 
altered expression in liver cancer samples was recently attributed to three distinct intronic TE 
polymorphisms. However, our qRT-PCR analysis on a panel of 10 human B-lymphocyte lines 
from the Coriell repository did not validate this putative association between the presence or 
absence of TEs and varied expression of MCC. We have also screened 22 primary liver cancer 
samples for these TEs, to study potential variation in MCC expression, in tumor and matched-
normal samples. Again, we could not confirm the reported correlation. We conclude that careful 
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case-by-case analysis is needed to evaluate the many possible biological impacts of TEs on gene 
expression. Our results suggest that in certain cases epigenetic controls may play a role in the 
mechanism of TE-mediated transcriptional disruption. 
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Lay Summary 
Transposable elements are repetitive sequences that are capable of movement in mice and 
humans. Novel insertions can result in genetic instability by initiating disruption of normal gene 
expression and function. Several studies provide compelling examples of genes in which 
transposon integrations induce transcriptional and functional disruptions. In this research, we 
studied the previously reported transposon-mediated gene disruption at two genes, Slc15a2 in 
mice and MCC in humans.  We further probed some potential mechanisms by which these 
polymorphic transposable elements, shown to be present in the gene introns, can disrupt gene 
function. Transposons and their roles in gene disruption and potential disease formation remain 
largely unexamined. Therefore, conducting this study will provide insight into the mechanisms 
by which transposon-mediated gene disruptions may occur in mammals. 
 
 
 
 
 
 
 
 
 
6 
 
Introduction 
Transposable elements (TEs), also known as “jumping genes” are mobile, repetitive 
elements that comprise around 50% of the human and mouse genomes
1, 2
. They are dispersed 
non-randomly across mammalian and other eukaryotic genomes
3
. Though most TEs are ancient 
relics that have become fixed in genomes over evolution, some are still actively mobilized and 
can initiate mutagenic effects
3
. In this research project, we have studied the biological impacts of 
TEs in mammals. We focused on two genes, Slc15a2 in mice and MCC in humans, where strong 
TE-mediated impacts on transcription have been implicated recently
4, 5
. In particular, we sought 
to investigate the mechanisms by which polymorphic TEs can disrupt gene expression. Several 
well-characterized examples include Agouti variable yellow (A
vy
), CDK5 activator binding 
protein (Cabp) and Notch-1 in the mouse genome and provide compelling evidence to the robust 
biological impacts that TEs can exert on gene expression
6-8
.  
Endogenous TEs can be subdivided into two major categories: DNA transposons and 
RNA transposons
3, 4
. DNA transposons move by a “cut-and-paste” mechanism, where a 
transposase excises and reinserts the transposon in a new genomic location
3, 4
. RNA transposons, 
also termed retrotransposons, use a “copy-and-paste” mechanism4. They are transcribed and 
converted into cDNA by a reverse transcriptase and inserted into a new locus
3, 4
. Unlike DNA 
transposons, retrotransposons make up a much larger part of the mammalian genome and are still 
actively mobilized
3
. Therefore, they are the main topic of discussion here. 
Classes of active, mammalian retrotransposons 
The four classes of retrotransposons most prevalent in mammalian genomes are long 
interspersed elements (LINEs), short interspersed elements (SINEs), SVA elements and ERVs
 3
. 
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This thesis will study transcriptional disruptions mediated by the L1, Alu, and Intracisternal A 
Particle (IAP) elements, which are specific types of LINE, SINE and ERV elements, 
respectively. These three TE classes are relatively young and still actively mobile in the human 
and mouse genomes
1
. 
L1 is known as the most important, mobile TE in the human and mouse genomes, with 
over 500,000 copies dispersed throughout in each
9, 10
. They are capable of transcribing their own 
endonucleases and reverse transcriptases, enabling them to undergo autonomous transposition
9
. 
The majority of L1 insertions are 5’ truncated and remnants of ancient retrotransposition events, 
which have become fixed in populations and accumulated many mutations
3, 9
. However, full-
length human L1s contain a bidirectional promoter at the 5’untranslated region (UTR) and have 
been implicated in examples of gene disruptions
1, 3
. Recently, we characterized another antisense 
(AS) promoter in the ORF1 of full-length mouse L1 elements, which was shown to initiate many 
fusion transcripts within endogenous genes
13
. Furthermore, L1 promoter hypomethylation has 
been linked to disease phenotypes such as multiple myeloma, chronic lymphocytic leukemia, and 
chronic myeloid leukemia, suggesting that de novo L1 transcription and consequent transposition 
may be increased in sporadic human cancers
9
.  
SINEs have reached a copy number of over 1 million in the human genome
9
. Some 
young elements continue to be actively mobilized
9
.  In the human genome, over 67% of SINEs 
contain Alu elements
12
. They are non-autonomous elements that must rely on other elements 
(such as LINEs) for retrotransposition
3
. Alus range from 100-400 bp in size and contain a strong 
internal promoter
1
. Most intronic Alu elements are enriched specifically near alternatively spliced 
exons and can thereby affect normal transcription in distinct ways
9, 12
.  
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Another class of non-autonomous TEs is SVA elements, which are a composite of SINE-
R, VNTR, and Alu sequences
14, 15
. Similar to Alu elements, they can be mobilized by L1 
machinery and represent another class of TEs that is capable of active movement in the human 
genome
15
.   
ERVs are not mobile in humans, but result in at least 10% of germline mutations within 
the mouse genome
12
. Of these, the ERK-K family is a group of young, full-length TEs that have 
intact ORFs and are flanked by virtually identical long terminal repeats (LTRs), enabling them 
for active retrotransposition
4
. Particularly, Intracisternal A-Particle (IAP) family members are 
known to be mobilized autonomously. These elements are transcriptionally activated due to 
DNA hypomethylation
4
. Furthermore, we recently showed that chromosomal locations of novel 
ERV integrants are completely different in highly divergent mouse strains. For example, when 
we compared genomes of B6, CAST, and SPRET mice, we found only 4 out of the several 
thousands of IAPLTR1 integrants mapped being observed at orthologous loci
4
. This indicates 
that novel ERV integrants may be a driving factor in speciation and genetic diversity within the 
mouse genome. 
Aberrant gene expression at various genetic loci such as Rpo1-4, Slc15a2, MCC, Agouti, 
Cabp, Notch-1, and APC in the mouse and human genomes has been attributed to novel TE 
integrations
4-7, 16. Due to TEs’ abundance and potential to induce variable gene expression, we 
contend that case-by-case analyses of such novel TE integrations and possible associations with 
altered transcript expression, structures, and functions will be fundamental to understanding their 
wide-ranging biological impacts.  
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TEs can introduce their own promoters and transcription factors and are thereby capable 
of initiating novel transcripts
3
. Recent findings indicated that between 6-30% of the entire 
mammalian transcriptome is initiated from TEs
17
. Indeed, around 18% of transcription start sites 
are found to overlap with repetitive elements such as L1s and SINES in the human genome
3
. For 
instance, in DNA Methyltransferase-1 (Dnmt1) mutant mice, 7 out of the 16 hypomethylation 
induced T-cell lymphomas were observed to contain a de novo IAP insertion in Notch-1
8
. This 
intronic integration drove the expression of a novel fusion transcript that induced the oncogenic 
function of Notch-1and contributed to lymphoma formation
8
. In addition, an HBV-human fusion 
transcript (HBx-LINE1) was found recently to be expressed in 23.3% of Hepatocellular 
Carcinoma (HCC) samples examined
18, 19
. The hybrid transcript was expressed as a long non-
coding-RNA, which in an oncogenic environment was correlated to decreased patient survival 
and tumor formation in mice
18, 19
.   
Novel insertions of TEs also can initiate ectopic activation of genes as illustrated at the 
Agouti viable yellow (A
vy
) and Axin-fused (Axin
Fu
) loci in mice
6, 20
. The integration of IAP 
elements within each of these two genes introduces a bidirectional promoter, which drives the 
ectopic activation of the two genes and leads to disease formation in mice
6
. The A
vy
 gene presents 
a compelling example of how promoter activity of a newly integrated TE can affect tissue-
specific expression of a relatively innocuous gene, normally resulting in sub-apical yellow bands 
on black hair, into a disease-causing gene, resulting in its over expression in a range of tissues 
and causing a yellow coat color, obesity, and type II diabetes
21
.  
Endogenous TEs have also been known to introduce alternative splice sites by providing 
ectopic splice acceptor and donor sites
3
. Intronic ERVs can trigger alternative RNA splicing by 
introducing endogenous, cryptic polyadenylation signals, resulting in differential transcriptional 
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expression
3
. Such an effect was recently shown at two genes, CDK5 activator binding protein 
(Cabp) and Solute carrier family 15, member 2 (Slc15a2)
4, 7
. In both cases, an intronic ERV 
initiates the premature termination of transcription by inducing the use of weak endogenous poly 
(A) signals that are typically not used in the normal expression of each gene
4, 7
. 
To investigate the mechanisms by which TEs can initiate the numerous examples of gene 
disruptions observed thus far, it is important to consider the factors known to affect gene 
expression more broadly in the mammalian genome. Typically, regulation of gene expression 
occurs primarily at the level of transcriptional and post-transcriptional gene regulation
22
. 
Transcriptional regulatory factors include DNA methylation, histone modifications, DNA-
binding transcription factors and other chromatin-associated factors
23
. Post-transcriptional gene 
regulators include transcriptional interference, double-stranded RNA interference, alternative 
splicing, and other mRNA stability factors
24
. This research project will focus how DNA 
methylation and antisense transcription can contribute to transcriptional and post-transcriptional 
gene silencing, respectively.  
Long non-coding RNAs (ncRNAs) including cis-natural antisense transcripts (cis-NATs) 
have recently been identified, forming a substantial portion of the mammalian transcriptome
25
. 
Recent reports indicate antisense transcription is widespread in cells and has been observed at 
over 50-70% of genetic loci
26
. While they have formerly been dismissed as “transcriptional 
noise”, there is growing evidence that cis-NATs may play a regulatory role on gene expression 
corresponding to the complexity of organisms – from prokaryotes to eukaryotes25, 27.  
A majority of the observed cis-NATs are linked to alternative splicing events observed in 
sense-antisense (SAS) gene pairs
28
. In addition, albeit less frequently than the SAS pairs, 
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antisense transcripts have been reported to be induced by polymorphic TE insertions and lead to 
variable sense gene expression
29
. Recently, 13 cases of human-specific antisense transcripts 
initiated by ectopic promoters introduced by TE insertions have been documented. This study 
further suggested that the variation in sense gene transcription as a result of the observed 
antisense transcription contributed to the evolutionary divergence between humans and 
chimpanzees
29
.  
Two potential mechanisms by which disruption of gene transcription can be mediated by 
antisense transcription include: (1) transcriptional interference, by which interactions of two 
RNA pol II complexes moving in opposing directions hinder transcription of one or both strands 
and (2) the formation of a double stranded RNA molecule, which could lead to post-
transcriptional silencing via RNA interference (RNAi)
29
.  
Transcriptional interference (TI) is the suppression of one transcriptional activity, directly 
and in cis by a second transcriptional activity
30
. TI is usually asymmetric with the promoter of 
one transcript being more active than that of the second
30
. Over 20% of total human 
transcriptional start sites in protein coding loci have been reported to occur within TE 
sequences
31
. Because most cis- NATs originating from intronic TEs are in the antisense 
orientation relative to host gene transcription, the two RNA pol II transcription complexes 
arising from convergent promoters can collide and result in early transcriptional termination of 
one or both of the transcripts
30, 31
. A study of a polymorphic mouse IAP integrant at Cabp 
suggested that antisense transcripts arising from its 5’-LTR promoter could result in premature 
transcriptional termination observed just upstream of the TE
7
.  
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Antisense transcription can also mediate gene expression through the formation of a 
double-stranded RNA molecule (dsRNA), which could lead to RNAi
29
. RNAi occurs in many 
diverse eukaryotic organisms
32
. The dsRNA is cleaved into short fragments of about 21-nt by an 
RNAase-III-type-endonuclease, Dicer, creating what are referred to as short interfering RNAs 
(siRNAs)
 32
. These complexes are then assembled into RNA-induced silencing complexes 
(RISCs), by which degradation of mRNA occurs and host gene expression is silenced
32
. RNAi 
remains a complicated and relatively unexplored component of post-transcriptional gene 
silencing
32
.  
In mammalian genomes, the primary role of DNA methylation has been to defend the 
mobilization and expression of TEs via transcriptional gene silencing
33, 34
. For instance, a high 
rate of TE-mediated gene disruptions was observed in the D. Melanogaster genome, which 
contains no genome defense in the form of DNA methylation
33
. In mammalian genomes, DNA 
methylation is controlled by a family of DNA methyltransferases that include Dnmt3a, Dnmt3b, 
and Dnmt1 and establish methylation patterns at differing points during embryonic 
development
35
. These enzymes are involved in two distinct DNA methyltransferase (MTase) 
activities observed in all mammalian cells: 1) a maintenance MTase activity in proliferating 
cells, to ensure the maintenance of methylation patterns during cell division and 2) a de novo 
MTase activity to reestablish the DNA methylation patterns during the post-implantation stage
36
.  
Through embryonic development, there is a complete erasure of epigenetic marks in 
primordial germ cells
37
. In mouse embryos, around 12.5 days post coitum (d.p.c), de novo DNA 
methylation patterns are reestablished by Dnmt3a and Dnmt3b 
35, 37
. Furthermore, tissue specific 
DNA methylation patterns are established during development by Dnmt3a and Dnmt3b and 
transmitted during cellular replication by the maintenance methylation activity, mediated by 
13 
 
Dnmt1
36
. We utilized genetic models of Dnmt1 mutations to analyze correlations in epigenetic 
regulation and TE-mediated gene disruption.  
As the maintenance MTase, Dnmt1 has the highest expression level in vivo and mutations 
in this gene seem to produce the most severe phenotypes relative to the other family of DNA 
MTases
38
. Dnmt1 is the best studied methylation enzyme in mammals and currently, four 
different mutant alleles have been generated: Dnmt
n
, Dnmt
s
, Dnmt
c
, and Dnmt
chip
 
39, 40
. This 
thesis makes use of Dnmt1
c
 mutation, which is a true null allele for the gene and Dnmt
chip
 which 
encodes a hypomorphic allele
40
.  
The Dnmt
c
 mutation represents a deletion of two highly conserved motifs in the catalytic 
domain and causes complete inactivation of the MTase function
40
. No Dnmt1 transcripts were 
detected in homozygous mutant mouse embryonic stem (mES) cells and no protein was 
observed
40
. The growth of homozygous mutant embryos (Dnmt 
c/c
) was arrested before the 8-
somite stage and at 9.5 d.p.c homozygotes displayed a distorted neural tube and died during 
gestation
37, 40
.  
A rescue of the null Dnmt
c 
allele by the expression of the gene’s cDNA in its cognate 
locus was also reported
40
. The cDNA was inserted upstream of the mutation using the cDNA 
homologous insertion protocol, resulting in the Dnmt1
chip
 allele. It is expressed from the gene’s 
endogenous promoter, resulting in hypomorphic expression
40
. Dnmt1
chip/c
 rescued mES cells still 
only express 10% of the DNA MTase relative to wild-type cells
41
. Further, compound 
heterozygous mice are runted, exhibiting only 70% of the body weight of WT mice, again 
corroborating the hypomorphic expression of the Dnmt1
chip
 allele
41
. 
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To gain insight into the underlying mechanisms of TE-mediated biological impacts 
within the mammalian genomes, we investigated correlations among DNA methylation, cis-
NATs, and transcriptional disruption at Slc15a2 and attempted to study these parameters at TE 
insertions in MCC. 
Slc15a2 encodes for PEPT2, which is one of the integral membrane proteins that mediate 
cellular transport of oligopeptides and peptide-like drugs
42
. These proton-coupled transporters of 
the SLC15 family are phylogenetically conserved membrane proteins
42
. PEPT2 is highly 
expressed in the mouse kidney and brains
4, 42
. Though Slc15a2 knock-out mice are viable and 
fertile, their physiological transport of certain oligopeptides such as beta-lactam antibiotics in the 
kidney and brain is significantly disrupted
42
.  
Our lab recently reported strong impacts by an intronic polymorphic ERV in disrupting 
expression at Slc15a2
4
. The presence of the ERV is strongly associated with 39-fold reductions 
in the 4-kb full-length transcript and a concomitant increase of 13-fold in a 1.2-kb truncated 
transcript (Figure 1A)
4
. This TE-mediated transcriptional disruption further results in a 3- to 9-
fold down regulation of PEPT2 protein (Figure 1B)
4
.  
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Figure 1: Polymorphic intronic ERV at Slc15a2 triggers gene disruption. (A) Northern blots. 
ERV at locus results in expression of a truncated, 1.2-kb transcript. Variable transcription is 
illustrated using 5’ probe (left) and 3’probe (right). No downstream 2-kb fusion transcript 
detected (right). (B) Western blots; the polymorphic ERV disrupts expression of the PEPT2 
protein, encoded by Slc15a2, in brain (left) and lung (right). This figure is copied from Li et al. 
Genome Research (2012).  
 
The polymorphic ERV in intron 7 of Slc15a2 results in prematurely truncated transcripts 
terminating 1.5-kb upstream of the TE
4. 5’-RACE cloning illustrated that the truncated transcript 
is terminated with a poly (A) tail sequence and contains part of intron 7 (Figure 2)
4
. Furthermore, 
this shorter isoform of the transcript does not contain any sequences of the ERV and terminates 
at two weak cryptic poly(A) signals
4
. 
 
 
 
16 
 
Figure 2: Gene schematic of Slc15a2 in DBA and B6 mice. Polymorphic ERV present in B6 
mice results in premature termination at intron 7 (black arrow). Truncated transcript terminates 
at two cryptic poly(A) sites (red arrows). This figure is copied from Li et al. Genome Research 
(2012).  
 
Another possible candidate gene where such gene disruption seems to be initiated by 
different polymorphic TEs is MCC 
5
. Three novel TE integrations were correlated with strong 
inhibition of MCC in liver cancer patients
5
. MCC expression was shown to dramatically inhibit 
the oncogenic β-catenin/Wnt signaling pathway that is activated in hepatocellular carcinomas 
(HCC)
 5, 43
; therefore, the TE-mediated down-regulation of MCC was indicated to result in the 
pathogenesis of HCC
5
. Four different cancer samples were either homozygous or heterozygous 
for the three TE polymorphisms in introns of MCC (Figure 3) 
5
.  
Figure 3: Site-specific PCR illustrates the presence of each TE-polymorph in the introns of 
MCC in tumor (T) and nontumor (NT) liver cancer samples. The presence of wt products 
indicates that sample is heterozygous for that TE. This figure was copied from Shukla et al. Cell 
(2013).   
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Two L1-Ta elements, belonging to the Ta subfamily of human-specific TEs known to 
actively retotranspose
9
, were mapped in introns 2 and 7 and were termed L1-beta and L1-alpha, 
respectively (Figure 4) 
5
. L1-beta is a full-length, 6-kb insertion, oriented antisense in relation to 
the gene. L1-alpha is truncated at 5.3-kb and is in the sense orientation
5
. Additionally, a novel 
Alu integration was observed in intron 4 in the antisense orientation in reference to MCC (Figure 
4) 
5
. The published results suggested that these three TE polymorphisms were the primary 
determinants of transcriptional disruption at the MCC locus in humans, although no mechanism 
was provided
5
.  
Figure 4: Gene schematic shows intronic TE polymorphisms. In humans, either one or none of 
the three intronic TEs depicted above is present at MCC. The L1-beta (red) and Alu (green) 
elements are full-length and in the antisense orientation relative to the gene. The L1-alpha (blue) 
is truncated and in the sense orientation. DES numbers indicate primers used to genotype the 
presence of each element in the TE-junction assay. 
 
 
In both cases at Slc15a2 and MCC, little is known about the mechanisms of the TE-
mediated gene disruption that has been reported. We hypothesized that a correlation between 
DNA hypomethylation at the ERVSlc15a2 would lead to an increase in truncated transcripts and 
decrease in read-through transcripts at Slc15a2. We proposed a model in which this local 
hypomethylation at the 5’-LTR of the ERVSlc15a2 would initiate an increase in antisense 
transcription from the ERV promoter, leading to an increase in truncated transcript levels. As we 
describe below, we found that variable expression levels of the prematurely truncated transcript 
at Slc15a2 were correlated to a decrease in DNA methylation levels at the ERVSlc15a2. We further 
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determined that differential DNA methylation was associated with variable antisense 
transcription from the bidirectional promoter of the intronic ERV. Our results suggested that 
antisense transcripts initiated by the TE integration may lead to a post-transcriptional regulation 
of Slc15a2 expression. By contrast, in the case of MCC, our preliminary data did not support an 
association between one of the three TE polymorphisms and the previously reported down-
regulation of MCC expression.  
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Materials and Methods 
Embryo collection 
Two different procedures were used to set up mating cages between Dnmt1
c/+
 and Dnmt1
chip/+ 
on 
the 129S1/SvlmJ and C57B1/6J strains. 
(1) Procedure 1: Mating cages were set up on the first day of each week. Females were 
weighed and checked for vaginal plugs each morning before 10:30am. If plug was 
observed, the day was labeled as 0 day post coitum (d.p.c). Female and male mice were 
then separated and the female was weighed every day to confirm pregnancy. If plug was 
not seen at the end of the week, female and male mice were still separated and female 
was continuously weighed in case of pregnancy for 21 d.p.c.  
(2) Procedure 2: Mating pairs were set up and maintained until a plug was observed. Each 
female mouse was checked for plugs and weighed each day. Weight gain and palpation 
were used to determine pregnancy.  
Tissue Dissection and preservation 
Embryonic tissues were collected using a dissecting microscope. Most tissues were divided in 
half to be used for RNA and DNA extractions. Brain, lung, and liver were collected for RNA. 
Tissues were kept in RNAlater (Ambion) at 4°C for 24h and were then frozen at -80°C for later 
use. Brain, lung, liver, and kidneys were collected for DNA. Tissues were directly kept in dry ice 
and frozen in the -80°C freezer. Embryonic limbs and tail were obtained for the purpose of 
genotyping.  
 
Genotyping: DNA preparation and PCR 
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Sample Preparation: Tail and limb DNAs were extracted using our standard DNA isolation 
protocol. Samples were digested using Proteinase K and incubated at 55°C overnight. DNA was 
precipitated using 100% isopropyl alcohol and resuspended in 1x TE.  
PCR: Three distinct conventional PCR assays were run to genotype Dnmt1 wildtype (with 
primes DES3517 and DES3518), Dnmt1
c
 (primers DES3420 and DES4821) and Dnmt1
chip
 
(DES3518 and DES3519) alleles. Conditions for the wildtype and Dnmt1
chip
 assays include: 
Platinum Taq hot start enzyme and annealing temperature of 61°C and extension time of 80 sec. 
Conditions of the Dnmt1
c
 PCR assay include: Platinum Taq hot start enzyme and annealing 
temperatures of 58 °C and extension time of 60 sec. (all primer sequences are detailed below)  
 
RNA extraction 
 
RNA was extracted using the TRIzol reagent protocol (Life Technologies). Samples were dried 
from RNAlater and homogenized using 2 mL of TRIzol reagent. 0.2 mL of chloroform was 
added for phase separation to 1mL of the homogenized tissue-TRIzol mixture. Samples were 
allowed to incubate for 2-3 minutes at room temperature. Tubes were centrifuged at 12,000 x g 
for 45 minutes at 4°C to allow the mixture to separate into a lower red phenol-chloroform phase, 
a white interphase, and a colorless upper aqueous layer containing the RNA. The upper, aqueous 
layer was carefully pipetted out and 0.6 mL of chilled 100% isopropanol was added. Samples 
were kept at -80°C overnight for RNA precipitation. Tubes were centrifuged for 30 minutes at 
4°C at 12,000 x g. Supernatant was discarded to isolate the white pellet at the bottom. RNA 
pellet was washed twice with 1 mL of chilled 70% ethanol and centrifuged at 15,000 x g for 15 
minutes each at 4°C. RNA pellet was air-dried for 5 minutes and resuspended in 25-30 µL of 
Nuclease-Free Water (Ambion), depending on pellet size. RNA purity was assessed by two 
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methods: 1) by using NanoDrop to quantify concentration and 260/280 and 260/230 ratios and 2) 
by running approx. 200 ng on a 1% agarose gel.  
 
DNA extraction 
 
DNA was extracted for bisulfite sequencing using the DNeasy Tissue Kit (Invitrogen) and the 
protocol provided was followed. This protocol is based on the lysis of cells and silica-based 
purification of DNA. Purity was assessed using NanoDrop.  
 
qRT-PCR 
 
Total RNAs extracted were synthesized into first-strand cDNAs for quantitative reverse 
transcriptase-mediated polymerase chain reaction (qRT-PCR) assays. 2.5 µg of total RNAs for 
each sample were primed for reverse transcription using oligo(dT) and SuperScript II Reverse 
Transcriptase (Invitrogen). qRT-PCR was performed using 1:20 dilutions of these cDNAs and 
Power SYBR Green PCR master mix (ABI) on a StepOnePlus instrument (ABI). Data were 
analyzed using the comparative CT method with an internal control house-keeping gene such as 
HPRT to normalize differences in sample loading.  
For the Slc15a2 read-through transcripts, primers DES4532 and DES4533 were used and 
truncated transcripts were quantified with DES4532 and DES4354.  
To quantify MCC expression as reported (4), we used primers DES5933 and DES5934. For 
downstream MCC expression, primers DES5917 and DES 5918 were used. 
 
Bisulfite Sequencing 
 
Extracted embryonic brain DNA was bisulfite treated using the CpGenome Turbo Bisulfite 
Modification Kit (Millipore). In brief, 0.5 µg of genomic DNA was used for bisulfite 
modification; this involves the chemical conversion of unmethylated cytosine to uracil. DNA 
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was amplified using primers DES2650 and DES2651, which are specific for the 5’-LTR of 
ERVSlc15a2. Amplicons were ligated into backbone of the TOPO- TA plasmid (Invitrogen) and 
transfected into One Shot TOP10 chemically competent E. coli cells (Life Technologies). 8-10 
individual bacterial clones per embryonic sample were sent for sequencing through GeneWiz.  
 
Transposon Junction PCR-Assay 
 
Primers were designed to detect the presence and absence of each transposon element on a filled-
/empty-target site basis. The 5’-junctions of L1-Ta elements were amplified to genotype positive 
samples. For the L1-alpha, primers DES5950 & DES5951 were used to amplify the 5’-junction 
and DES5949 &DES5950 were used for the empty target site (ETS). The L1-beta 5’junction was 
assayed using DES5692 & DES5693 and  primers DES5693 & DES5694 were used for the ETS. 
For the short Alu, primers, DES5696 & DES5697 were designed in the flanking regions and 
amplified the entire element if present. Platinum Taq hot-start enzyme was used for all PCR 
reactions. PCR conditions for the L1-alpha: annealing temperature (Ta) of 58°C and extension 
time of 30 sec; for the L1-Beta and Alu elements: Ta of 60°C and extension time of 30 sec. 
 
F9 Drug Treatment  
 
The mouse teratocarcinoma stem cell line (F9) was cultured in a complete growth medium 
according to the ATCC protocol. F9 cells were treated with 2 µM 5-aza-dC, 300 nM Trichostatin 
A (an inhibitor of histone deacetylase, HADC) or with a combination of the two drugs for 24 
hours at 37°C, 5% CO2. After treatment, total RNAs of treated and untreated F9 cells were 
isolated following the TRIZOL RNA isolation protocol.  First-strand cDNA from RNAs was 
synthesized by Superscript II reverse transcriptase (Invitrogen). RT-PCR was conducted using 
different PCR primer combinations to check the expression of Slc15a2 read-through, terminated, 
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antisense from ERV 5’ LTR and fusion transcripts from ERV 3’ LTR.  The expression of mouse 
HPRT1 gene was a loading control. This work was conducted by Dr. Jingfeng Li.  
 
Slc15a2 Minigene Constructs 
 
Slc15a2 minigene construct was made by homologous recombination using the modified DH10B 
cell strain DY380. A/J and B6 mouse DNAs were amplified using PCR and co-transformed with 
the linearized plasmid into cells. To replace Slc15a2 endogenous ERV with different promoters, 
plasmid pFN21A DNA and human and mouse genomic DNAs were amplified to get CMV, 
human L1.3 5’UTR, mouse L1 5’UTR, and mouse L1 antisense promoters. To create mutations 
at the Slc15a2 cryptic poly (A) site, site mutagenesis was performed according to the Strategene 
Quick mutation kit. This work was conducted by Dr. Jingfeng Li.  
 
RNA-Seq 
 
We obtained RNA-Seq data for 14 mouse strains from Sanger Institute's mouse genome 
sequence project
43
.  Unstranded RNA-Seq analysis was performed using 75 bp x 2 paired end 
reads with the Illumina GAII platform.  We downloaded aligned RNA-Seq reads in BAM format 
(ftp://ftp-mouse.sanger.ac.uk) and compared expression levels of annotated genes and 
transcripts.  We quantified the expression levels for genes annotated in the Ensembl database 
(v64).  Normalization and comparison of samples were performed following the standard 
Cufflinks protocol
44
.  
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Primer Name Primer Sequence Primer Description 
DES3517 AGCCAGTTGTGTGACTTGGAAAC Dnmt1 wt genotyping 
 
DES3518 
CAATGATAGCTCTCTGGTGTGAC Dnmt1 wt & Dnmt1
chip
 
genotyping 
DES3519 GCTTCCTTCTCAGCACCAG Dnmt1
chip
 genotyping 
DES3420 AGGACCAAGGAAATGTGCTG Dnmt1
c
 forward (F) primer 
DES4821 GCCTTCTATCGCCTTCTTG Dnmt1
c
 reverse (R) primer 
DES4532 CTTGATTTCTATGTTCATCACACCC Slc15a2 exon 7  (F) 
DES4533 ATCCTTTTCCACTCCACTCAC Slc15a2 exon 8, read-through 
transcript primer 
DES4534 TGTACATCTTGCTTCCCATTGC Slc15a2 intron 7, truncated 
transcript primer 
DES5672 TGAAGAGCTACTGTAATGATCAGTCAAC mHprt (F) 
DES5673 AGCAAGCTTGCAACCTTAACCA mHprt (R) 
DES2650 YGTAGTTTTGGTTTTGAAATGAAG ERVSlc15a2 5’LTR, (F) bisulfite 
primer 
DES2651 CATAAAAAAACTTCTAACAAACACTC ERVSlc15a2 5’LTR, (R) bisulfite 
primer 
DES5950 AGCTGCAGGTCTGTTGGAAT MCC L1-alpha 5’ junction 
DES5951 CATGATGCTTCACCCCCTAA MCC L1-alpha 5’ flanking 
DES5949 CACAGAGGTTACCCCTTGCTTTG MCC L1-alpha 3’ flanking 
DES5692 AACTCCCTGACCCCTTGC MCC L1-beta 5’ junction 
DES5693 GCATCATGAGTTCAGCCTCA MCC L1-beta 5’ flanking 
DES5694 GGGGATTCTCTCTCTCGCTC MCC L1-beta 3’ flanking 
DES5696 TCCCCACACCACTTACACAA MCC Alu 3’ flanking 
DES5697 TTGAGTCATCATCCCAGTGC MCC Alu 5’ flanking 
DES5933 TATGGAAACGACTCCTCGGC MCC Exon 3a 
DES5934 TCTCATGAGGTGGGACTGCT MCC Exon 5 
DES5917 CCCACTCACTTCAGGACTGC MCC Exon 11 
DES5918 TCCTCCAAGGTTATGGTCAGG MCC Exon 12 
DES4330 AACAGGGGACATAAAAGTAATTGG hHPRT (F) 
DES4331 GCGACCTTGACCATCTTTG hHPRT (R) 
 
 
 
 
 
 
 
25 
 
Results 
TE-mediated transcriptional disruption was recently shown to occur at two candidate 
genes, Slc15a2 in mice and MCC in humans
4, 5
. We investigated these novel TE insertions to 
gain insight into the mechanisms by which such disruption in gene expression may occur.  
We performed bioinformatics analysis of RNA-Seq expression data at Slc15a2, which 
attests to importance of looking at particular transcript variants to be able to detect TE-mediate 
gene disruptions. This work was performed by our bioinformatics expert, Dr. Keiko Akagi. The 
figure reveals that no difference in level of expression was observed when the average exon 
expression of Slc15a2 across 14 diverse mouse strains was analyzed (Figure 5A).  
 By contrast, there was a very significant difference when studying full-length transcripts 
and truncated transcripts at the host gene in B6 versus the other 13 strains displayed here (Figure 
5B & 5C). B6 mice are the only strain in this data that harbor the ERV insertion at Slc15a2 (here 
after referred to as ERVSlc15a2) (Figure 2).  
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Figure 5: Transcriptional variation at Slc15a2 in brain tissues of 14 diverse mouse strains, as 
determined from publicly available RNA-Seq data. (A) Slc15a2 gene expression, by observing 
average expression across all exons in the host gene shows no variation in B6 (arrow) relative to 
the other strains. (B) Full-length transcript level expression analysis illustrates a significant 
decrease specifically in B6 mice (arrow). (C) Expression of the Slc15a2 truncated transcript was 
strongly increased in the B6 strain (arrow) due to the presence of the intronic ERV. FPKM, 
fragments per kilobase of exon per million fragments mapped. 
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An initial in vitro analysis was conducted in our lab by Dr. Jingfeng Li (unpublished 
data) to determine a possible role of epigenetic regulation at the ERVSlc15a2 on Slc15a2 
expression levels. Mouse embryonal carcinoma (F9) cell lines typically do not express Slc15a2 
robustly (Figure 6). However, when cells were treated with 5-Aza-2-deoxycytidine (5-azadC), a 
drug that induces DNA demethylation, an increase in expression of both the upstream transcript 
and the prematurely terminated transcript at Slc15a2 was observed (Figure 6). Results indicate 
that DNA methylation may play a central role in differential transcription mediated by 
ERVSlc15a2.  
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Figure 6: Increased expression of truncated transcripts in treated F9 cells, as visualized from 
RT-PCR assays of particular transcript structures (right). F9 cells do not express Slc15a2 
robustly as is illustrated by the absence of a band at both read-through and terminated transcripts. 
Upon treatment with the demethylating drug, 5-Aza-2-deoxycytidine (5-azadC), expression of 
the terminated transcript (ex1/intr7) was significantly increased. Concomitant increase in 
antisense transcription (LTR/intr7) from ERV promoter was also observed. F9 cells were also 
treated with Trichostatin A (TSA), a histone deacetylase inhibitor. However, antisense and 
truncated transcription was not as robustly increased as was the case with demethylation. This 
figure was generated by Dr. Jingfeng Li in the Symer laboratory.  
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To study whether this correlation occurs in vivo, we generated Dnmt1
chip/c
 compound 
heterozygous mutants. Our previous assessments of DNA methylation levels in tissues of adult 
Dnmt1 mutant mice revealed no significant decrease in methylation (data not shown). This is 
distinct from the initial characterization of Dnmt1
chip/c
 mice, which described these mutants to be 
runted and to develop aggressive T-cell lymphomas due to severe hypomethylation
41
.  
We observed that Dnmt1 chip and c alleles were also not inherited at expected Mendelian 
ratios (Table 1).  Thus, the lack of hypomethylation observed in adult Dnmt1
chip/c
 mice and non-
Mendelian inheritance of the two alleles indicates that they may be exerting a highly deleterious 
impact on embryonic development. Therefore, to obtain a hypomethylated mouse model for this 
study, we collected tissues from embryos at various developmental stages from intercrosses of 
Dnmt1
chip/+
 and Dnmt1
c/+
 parents. We expected an increased frequency in the Dnmt1
chip/c
 
compound-heterozygous mutants embryos relative to surviving adults (Table 1).  
 
Intercross Mut/mut Mut/+ +/+ (wt) N P-Value  
Adult: Dnmt1
chip/+ 
X 
Dnmt1
c/+ 
3.7% 55.6% 40.7% 54 0 Non-
Mendelian 
Embryonic: 
Dnmt1
chip/+ 
X Dnmt1
c/+
 
17% 41.5% 41.5% 53 0.037 Non-
Mendelian 
 
Table 1: Non-mendelian inheritance of the Dnmt1
chip/c
 genotype. Low allelic frequencies suggest 
that the two mutant alleles may be exerting a strong deleterious impact on embryonic 
development. This is further confirmed by the much lower allelic frequency observed in 
compound-heterozygous mutant (mut/mut) adult mice relative to that seen in embryos. 
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We conducted bisulfite sequencing to verify a hypomethylated state at ERVSlc15a2 in 
Dnmt1 mutant embryos. Bisulfite sequencing is a standard procedure that converts unmethylated 
cytosines in CpG dinucleotides to uracil and therefore, this method is used to determine the 
amount of methylated cytosine present
46
. We modified genomic DNA from various embryonic 
brain tissues of Dnmt1
chip/c
 and wildtype embryos using bisulfite treatment. PCR products were 
Topo cloned (Life Technologies). We then amplified particular genomic regions using primers 
specific to the 5’-long terminal repeat (LTR) of the ERVSlc15a2. Eight to 10 sequence reads were 
obtained per embryonic tissue sample. Our results indicated that Dnmt1
chip/c
 embryos are on 
average 65% methylated relative to Dnmt1 wildtype embryos, which exhibit an average of 95% 
methylation (Figure 7). Furthermore, larger differences in methylation were seen in wildtype 
versus mutant mice at younger developmental stages: 32.4% difference in methylated cytosines 
in 14 days d.p.c embryos in comparison to the 24.8% difference in day 1 newborn (NB) embryos 
(Figure 7). All embryos harvested were of either the 129S1 or B6 strain. Both of these mouse 
lineages are known to contain the ERV at Slc15a2 in homozygosity
5
.  
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Figure 7: Validation of hypomethylation in Dnmt1
chip/c
 mouse embryos relative to the wildtype 
genotypes. DNA methylation at the 5’ LTR of the IAP was quantified using bisulfite sequencing 
of mouse embryonic brain DNA. Primers were used to PCR-amplify a 513-nt product, assessing 
17 CpGs. Filled (black) circles and unfilled (white) circles indicate methylated and unmethylated 
cytosines, respectively. The number beside each panel represents the percentage of cytosines in 
CpG dinucleotides that were methylated in the amplicons measured. 
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Next, to study possible effects of altered epigenetic control at the ERVSlc15a2 on variable 
expression of Slc15a2 in vivo, we compared RNAs isolated from wildtype and Dnmt1
chip/c
 
embryos, which we had validated to be hypomethylated through bisulfite sequencing. As noted 
above in bisulfite sequencing, we collected embryos at various developmental stages – ie. 14 
d.p.c., 16 d.p.c, 18 d.p.c and day 1 NB.  
Variable expression levels of the 1.2-kb truncated transcript and the 4-kb read-through 
transcript were quantified from RNA obtained from embryonic brain tissues using quantitative 
reverse transcriptase PCR (qRT-PCR). Relative expression of the read-through transcript was 
significantly down-regulated in hypomethylated embryos at all developmental stages 
investigated (Figure 8A). Conversely, we found that expression of the prematurely truncated 
transcript was up-regulated with a decrease in DNA methylation (Figure 8B).  
This is consistent with our analysis in F9 cells, which illustrated that treatment with a 
demethylating drug leads to an increase in premature transcriptional truncation (Figure 1). 
However, expression of the truncated transcripts did not vary as significantly as expression of 
read-through transcripts. And as the difference in methylation levels between mutant and wt 
embryos decreased at later developmental stages, the variation in expression of truncated 
transcripts also decreased. For instance, in day 1 newborns, no significant difference in the 
expression of truncated transcripts is observed. In 14 d.p.c embryos, a greater difference in 
truncated transcript expression was observed between Dnmt1 wildtype and mutant genotypes, 
which also exhibit the greatest difference in methylation levels. When we calculated the ratio of 
truncated transcripts to read-through transcripts, we noted a significant increase in Dnmt1
chip/c
 
embryos relative to wildtype embryos at all developmental stages (Figure 8C). This indicates that 
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the two transcriptional forms seen are inversely related to each other and both were associated 
with differential DNA methylation at the 5’LTR of ERVSlc15a2. 
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Figure 8: Expression of truncated transcripts is increased in hypomethylated embryos. qRT-PCR 
of extracted RNA from embryonic brain tissue of mice at different developmental stages. (A) 
Expression of read-through transcripts was significantly reduced in Dnmt1 mutant embryos (red) 
relative to Dnmt1 wt embryos (blue). (B) An increase in the amount of prematurely terminated 
transcript was observed with increasing DNA hypomethylation. However, truncated transcripts 
did not vary as significantly as read-through transcripts due to differential DNA methylation. No 
significant increase in truncated transcripts between Dnmt1
chip/c
 embryos and wildtype in day 1 
newborns (NB) was observed. (C) The ratio of truncated/RT transcripts significantly increased in 
hypomethylated embryos relative to wildtype embryos across all developmental stages. 
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The observed correlation of the increase in expression of truncated transcripts with DNA 
demethylation at the 5’ LTR of ERVSlc15a2 could result from antisense transcripts originating 
from the bidirectional promoter at the ERV. To investigate this model of transcriptional 
disruption, we studied changes in antisense transcript expression, DNA methylation, and 
truncated transcription in F9 cells. This work was part of the initial study conducted by Dr. 
Jingfeng Li from the Symer lab. His RT-PCR analysis showed that F9 cells treated with 5-azadC 
had increased expression of antisense transcription (unpublished data, Figure 6). This putative 
increase appeared to be correlated to an increase in terminated transcript expression, as 
mentioned previously (Figure 6). Meanwhile, untreated F9 cells with usual levels of methylation 
showed expression of neither the antisense transcripts nor the terminated transcripts (Figure 6). 
These data suggest that DNA methylation may be a major epigenetic regulatory factor that 
governs the disruption of transcription at Slc15a2, by potentially silencing antisense transcription 
from the polymorphic ERVSlc15a2.  
To study how increases in antisense transcript expression affect normal sense expression 
of the host gene, we generated a minigene construct, in which we manipulated the activity of the 
bidirectional promoter at the 5’LTR of the ERVSlc15a2. This work was conducted by Dr. Jingfeng 
Li from our lab. The minigene construct contained a CMV promoter to replace the native gene’s 
promoter, part of exon 1, exon 6, intron 6, exon 7, intron 7 and exon 8 of Slc15a2 and a poly(A) 
signal (Figure 9A). The ERVSlc15a2 was replaced by various different promoters: CMV, a mouse 
L1 5’ UTR promoter, the mouse L1 antisense promoter, and the mouse L1 5’ UTR promoter in 
the sense orientation to the gene (Figure 9A). Our qRT-PCR results analyzing the expression of 
prematurely truncated transcripts in relation to the strength of the antisense promoter indicated 
that in the introduction of a strong promoter such that from CMV, replacing ERVSlc15a2 increased 
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antisense transcription and led to a significant increase in the prematurely truncated transcript at 
Slc15a2 (Figure 9B).  
Conversely, when a promoter was introduced in the sense orientation, we observed no 
expression of the terminated transcript (Figure 9B). This indicates that there is a strong 
correlation between antisense transcription at the ERVSlc15a2 and premature transcriptional 
disruption at Slc15a2. It should be noted that in the presence of no ERVSlc15a2 , there is still a 
small amount of terminated transcription present (Figure 9B). This could be attributed to the 
presence of two weak cryptic poly(A) termination signals just downstream of exon 7, where the 
truncated transcript is terminated.  
To assess the importance of the stronger one of the two cryptic poly(A) sites, we used 
site-specific mutagenesis to manipulate the same minigene construct (Figure 10A). In the 
presence of the endogenous poly(A) signal, there was some expression of terminated transcripts, 
even in the absence of ERVSlc15a2 (Figure 10B). However, when the poly(A) signal was mutated, 
no terminated transcription was observed in the absence of the ERVSlc15a2 and a reduced level of 
truncated transcripts is observed when the ERVSlc15a2 was present (Figure 10B). Although it was 
reduced, the amount of truncated transcript still present may be attributed to the presence of the 
second weak poly(A) site. 
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Figure 9: Antisense promoter activity is correlated to level of truncated transcript expression in 
our analysis of Slc15a2 transcripts in a mini gene construct. The construct includes part of exon 
1, exon 6, intron 6, exon 7, intron 7 and exon 8 sequences from the native Slc15a2 gene in mice. 
The native gene promoter was replaced by a CMV promoter and a poly(A) termination signal 
was added to the end of the construct. (A) The ERVSlc15a2 was replaced by various promoters of 
differing strength. (B) qRT-PCR of terminated transcripts at Slc15a2. In the presence of a strong 
promoter such as CMV, through which antisense transcription is increased, the expression level 
of truncated transcripts is significantly amplified. When the L1 5’UTR promoter is present in the 
sense orientation relative to the native host gene, no truncated transcripts are observed due to the 
absence of antisense transcription from the ERVSlc15a2. This figure was generated by Dr. Jingfeng 
Li in the Symer laboratory. 
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Figure 10: Cryptic poly(A) signals are important for transcriptional termination at Slc15a2. (A) 
Minigene construct (as described above) with poly (A) signal sequence mutated as shown 
(indicated in red). (B) qRT-PCR of terminated transcripts. In the presence of a mutation at the 
poly(A) site, reduced transcriptional truncation is observed. Some expression of this transcript 
was still observed in the presence of the ERVSlc15a2 and poly(A) mutation, which could be 
attributed to the presence of a second, weaker poly(A) site upstream. This figure was generated 
by Dr. Jingfeng Li in the Symer laboratory. 
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Another example of TE-mediated gene disruption that was recently published is Mutated 
in Colorectal Cancer (MCC) in the human genome
5
. The presence of three polymorphic TEs in 
the introns of MCC was shown to contribute to significant down-regulation of the tumor 
suppressor in liver cancer patients
5
. Dr. Keiko Akagi, a bioinformatics expert in our lab, checked 
publicly available Complete Genomics datasets for the frequencies of the three TEs at MCC. We 
found that the allele frequency for each of the reported TE-polymorphisms was 9.1% for L1-
beta, 1.9% for AluYb8, and 21.2% for the L1-alpha insertion. The relatively high frequency with 
which the three TE integrants are present at the MCC locus in humans – over a total of 30% - 
within the samples analyzed raised a question about whether the presence of each TE actually 
could lead to the putative strong down-regulation in gene expression. Therefore, our first goal 
was to validate whether this phenomenon actually occurs within humans diagnosed with liver 
cancer. If confirmed, we then would study the mechanisms by which this TE-mediated gene 
disruption occurred in this important tumor suppressor gene. 
To first validate the presence of the three TEs at MCC, we obtained 10 human 
lymphoblastoid cell lines, previously known to contain one or none of the TEs and 22 human 
liver cancer samples – ie. tumor and matched normal sample. A TE-junction assay was 
developed for each TE, with transposon sequence-specific and degenerate primers for genomic 
PCR amplification. Two sets of primers were designed to amplify the 5’- and 3’- junctions of the 
L1-alpha element present in intron 7 of MCC. The 3’-junction primers failed to cleanly amplify 
positive samples and produced many non-specific products. Samples were deemed to be positive 
for this element upon the presence of approximately a ~230-bp product from the 5’-junction of 
the TE. A third set of primers was designed to amplify an empty target site (ETS) on alleles that 
contained no intronic TEs at MCC. All samples including those positive and negative for the L1-
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alpha contained a 550-bp product, indicating the presence of an allele without TE integration. 
We validated 3/10 lymphoblastoid cell lines (data not shown) and 4/22 (18.2%) of human liver 
cancer samples to be heterozygous for the L1-alpha element (Figure 11A). All but one of the 
lymphoblastoid cell lines previously predicted to contain the L1-alpha were successfully 
validated with this junction PCR assay. We do not know the reason for this discrepancy. 
A similar TE-junction assay was designed to determine the presence and absence of the 
L1-beta element in intron 2 of MCC. Again, the 3’-junction assay did not cleanly amplify the 
targeted sequence and produced many non-specific bands. All samples containing a 260-bp 
product from the 5’-junction of the TE were positive for the L1-beta. And all negative and 
positive samples produced a 350-bp product for the ETS assay. We confirmed the presence of 
the L1-Beta in heterozygosity in 2/10 lymphoblastoid cell lines and in 3/22 (13.6%) of liver 
cancer samples (Figure 11B).  
For the Alu-Y element, two primers were designed flanking the element. Samples 
heterozygous for the Alu contained a 220-bp band from the allele negative for the TE and a 470-
bp product indicating the presence of the element. 1/10 lymphoblastoid cell lines and 2/22 
(9.1%) liver cancer samples were heterozygous for the Alu element in intron 4 of MCC (figure 
11B).  
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Figure 11: Validation of intronic TE polymorphisms at MCC. TE-junction PCR assay was 
conducted in liver cancer samples. (A) Positive elements for the L1-alpha contain a ~230-nt 
product (indicated by blue arrows) in the 5’ junction assay. Each sample checked had a ~550-nt 
band for the ETS, indicating that the L1-alpha was present in heterozygosity. (B) Samples are 
positive for the L1-beta element if a ~260-nt product was present in the 5’Junction assay. All 
samples contained a ~350-nt band for the ETS, illustrating the presence of the L1-beta in 
heterozygosity. Samples that are heterozygous for the Alu element contained a ~470-nt for the 
positive-TE allele and a ~220-nt for the unfilled or TE-negative allele.  
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To validate the putative correlation between the presence of one or none of the three 
polymorphic TE and down-regulation of MCC expression, we synthesized the same qRT-PCR 
primers used previously
5
. The two primers were designed in exon 3a and exon 5 –downstream of 
the L1-Beta and upstream of the Alu and L1-alpha TEs
5
. We also obtained additional primers 
across all exons of MCC. 
Our analysis did not confirm the correlation previously reported
5
 between the presence of 
one of the intronic TE polymorphs and variable expression at MCC (Figure 12A). We also 
checked MCC expression levels at exon 11 and exon 12, downstream of all three TE 
polymorphisms. This assay illustrated similar results. Again, no consistent down-regulation of 
MCC due to the presence of one or none of the TEs was observed (Figure 12B). 
Because TE-mediated MCC downregulation was previously examined in liver cancer 
patients
5
 we next obtained 22 liver cancer samples to investigate this reported correlation. We 
conducted a similar qRT-PCR analysis on 8/22 samples that were previously validated to be 
positive or negative for each TE polymorphism, by using the same primers in exon 3a and exon 5 
(as described above). Again, as was the case in lymphoblastoid cells, we observed no correlation 
between MCC expression and the presence of one or none of the three intronic TE polymorphs 
(Figure 13A & 13B).  
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Figure 12: MCC expression does not correlate to the absence or presence of an intronic TE in 
our analyses of 10 human lymphoblastoid cells. (A) qRT-PCR analysis quantified expression at 
from exon 3a-exon5. (B) Expression quantified downstream of all intronic TE polymorphs in 
exons 11 and 12 of MCC illustrated results similar to those observed upstream in the gene.  
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Figure 13: Relative MCC expression in liver cancer DNA – tumor (T) and matched-normal (N). 
Presence of polymorphic intronic TEs does not correlate to a down-regulation of MCC. (A) qRT-
PCR analysis. 5 different liver cancer samples containing either one or none of the three TEs 
were analyzed for MCC expression. (B) Two additional liver cancer samples positive for L1-beta 
(red) and one additional for L1-alpha (blue) were analyzed. 
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Discussion 
In this thesis, we evaluated the roles played by TEs in disrupting gene expression by 
studying two separate genes, Slc15a2 in mice and MCC in humans. In the case of Slc15a2, our 
lab had previously defined the premature transcriptional termination that occurs as a result of an 
intronic polymorphic ERV
4
. This transcriptional variation was further shown to cause a 
disruption in gene and protein function
4
. A conceptually similar phenomenon, whereby intronic 
TEs could cause gene variation and functional disruption, was subsequently described at the 
MCC locus in humans
5
. We investigated both loci to gain an understanding of the mechanisms 
by which intronic transposons may be causing the reported transcriptional disruption.  
RNA-Seq data of Slc15a2 expression illustrated the importance of investigating transcript 
variants of genes at which TE-mediated transcriptional disruption has the potential to occur. An 
average expression level across all exons of Slc15a2 did not show a difference across the 14 
diverse mouse strains depicted (Figure 5). However, upon further analysis of full-length 
transcript and truncated transcript levels, a significant difference was observed in B6 mice in 
comparison to the other 13 strains (Figure 5). Our results point to the value of studying transcript 
variants in order to gain insight into the mechanisms by which gene disruptions can be initiated 
by intronic TEs. 
DNA methylation is known to be highly enriched at CpG dinucleotides in TEs across the 
mammalian genome and typically acts as a form of genomic defense to inhibit TE-mediated gene 
disruption
25, 27
. We found this to be true in our study of the mechanism of ERV-mediated 
disruption of Slc15a2 transcription. Our analysis in mouse embryonal carcinoma (F9) cells 
provided evidence that DNA methylation may act as a major form of regulation at the ERVSlc15a2. 
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Upon treatment with a demethylating drug, 5-Aza-2-deoxycytidine, F9 cells exhibited a 
significant increase in expression of both the upstream sense transcripts and the prematurely 
truncated transcript at Slc15a2 (Figure 6).  
In studies of the classic Agouti gene in mice, it has been reported that Dnmt1 is important 
in the maintenance of IAP methylation during embryonic mouse development
21
. We studied this 
effect in vivo by generating mouse embryos and newborn pups that were hypomorphic for 
Dnmt1.  We sought to study expression of Slc15a2 in Dnmt1
chip/c
 mice, which were established 
beforehand to be hypomethylated
32
. However, our attempts to obtain a hypomethylated mouse 
model had not succeeded thus far. Unlike reports indicating that Dnmt1
chip/c
 mice develop thymic 
tumors at about 4-8 months of age and generally do not survive past 10 months of age
32
, our 
mutant mice were healthy well beyond one year. Bisulfite sequencing in these adult mice further 
illustrated that there was no significant DNA hypomethylation (data not shown). Our analysis 
also showed that the two mutant alleles, Dnmt1 chip and c were not inherited at expected 
Mendelian ratios (Table 1). Together, these findings indicated that the Dnmt1
chip/c
 genotype may 
be posing deleterious impacts during embryonic development.  
Therefore, we collected embryos at various developmental stages from Dnmt1
chip/+
 and 
Dnmt1
c/+ 
intercrosses. As we anticipated, there was an increase in the frequency with which the 
Dnmt1
chip/c
 genotype was observed when compared to surviving adult genotypes (Table 1). We 
validated hypomethylation by bisulfite sequencing, with the use of primers specific to the 5’LTR 
of the ERVSlc15a2. Dnmt1 mutant embryos displayed about 25-30% reduction in methylation at 
this LTR in comparison to Dnmt1 wt embryos (Figure 7). Furthermore, we saw a slight reduction 
in DNA methylation levels in embryos at earlier developmental stages; mutant and wildtype 
embryos at 14 d.p.c were less methylated than day 1 newborn embryos. This is consistent with 
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recent reports which indicated that a wave of demethylation occurs just prior to implantation 
around stage 12.5 d.p.c.
37
. All embryos were bred on the 129S1 and B6 strains, which are known 
to be homozygous for the ERVSlc15a2  
4
. Therefore, the observed variation in local 
hypomethylation at ERVSlc15a2 in mutant embryos allowed us to investigate the effects of 
epigenetic regulation and differential transcription at Slc15a2.  
Our qRT-PCR analysis studying the expression of truncated and read-through transcripts 
illustrated a significant down-regulation of read-through transcripts in hypomethylated embryos 
(Figure 8). A concomitant increase in prematurely truncated transcripts was observed with the 
decrease in DNA methylation (Figure 8). We acknowledge that more mutant embryos are 
necessary to corroborate our preliminary analysis of DNA methylation variation in vivo. 
However, our results thus far indicate that a reduction in methylation at the 5’LTR of the 
ERVSlc15a2 was associated with the observed TE-mediated disruption of gene transcription. This 
provides us more insight about the mechanisms by which TEs can result in genomic 
mutagenesis. We confirmed that DNA methylation is important in the epigenetic silencing of 
TEs and that it acts as a form of genomic defense to prevent TE-mediated gene disruption in the 
mammalian genome
33
. 
Because TEs can introduce ectopic promoters, they are known to initiate their own 
transcripts – fusion transcripts or antisense transcripts that can disrupt host gene function3. The 
5’ LTR of the ERVSlc15a2 contains a bidirectional promoter, which was previously shown to 
initiate transcripts antisense to Slc15a2 
4
. Along with the increase in truncated transcripts that 
was seen in our initial analysis in demethylated F9 cells, a simultaneous increase in transcripts 
arising from the antisense promoter at the ERVSlc15a2 was observed (Figure 6).  
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Next, we sought to manipulate the strength of this antisense ERV promoter and 
investigate the effect of variable expression of antisense transcripts. Therefore, we generated a 
minigene construct, containing essential parts of the native Slc15a2 (Figure 9A). When 
expression of the antisense transcripts was increased by replacing the native ERV promoter with 
a strong, CMV promoter, the expression of the prematurely truncated transcript was augmented 
(Figure 9B).  Conversely, when replaced by a promoter oriented in the sense direction to gene, 
whereby no antisense transcripts were generated, no truncated transcription was expressed 
(Figure 9B). Our data revealed that antisense transcription from ERVSlc15a2 is positively 
correlated to the level of truncated transcription at Slc15a2. This suggested that transcriptional 
interference may be occurring at Slc15a2, in which two convergent promoters send two 
transcripts toward one another and result in the early termination of one of the transcripts
30
. This 
model is similar to one that was suggested to occur at the Cabp locus in mice
7
. However, this 
field of study remains largely unexplored. 
Furthermore, we reported that the endogenous cryptic poly(A) signal present in intron 7 
of Slc15a2 is important in the presence of the ERVSlc15a2 to initiate the increase in truncated 
transcript expression (Figure 10). Mutations at this poly(A) site resulted in a strong decrease in 
terminated transcript expression, indicating that the ERVSlc15a2 induces the use of this weak 
termination signal to disrupt host gene expression. However, a small amount of truncation was 
still observed in the absence of ERVSlc15a2 and this could be explained by the presence of another, 
weaker poly (A) site at that locus, as was previously described
4
.  
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Figure 14: Proposed model of TE-mediated transcriptional disruption occurring at Slc15a2. 
Antisense promoter at the 5’LTR (red arrow) initiates antisense transcripts (blue arrows). 
Transcriptional interference could induce premature truncation at Slc15a2 at a cryptic poly(A) 
signal (black arrow).  
 
With this evidence, we propose a model for the mechanism by which the premature 
transcriptional truncation mediated by the ERVSlc15a2 could occur under hypomethylated 
conditions (Figure 14). LTRs in the ERV in intron 7 of Slc15a2 introduce an ectopic promoter 
within the native gene. Antisense transcripts initiated from this promoter could then result in the 
observed premature termination of Slc15a2 transcripts in two main ways: (1) transcriptional 
interference, which occurs when the two RNA polymerase II complexes moving towards each 
other collide and (2) RNA interference, during which the formation of a double-stranded RNA 
molecule leads to post-transcriptional silencing of gene expression
29
.  
Further investigation will be required to gain additional insight into just how TE-initiated 
antisense transcripts may be mediating transcriptional disruption at Slc15a2. Current work being 
conducted in our lab to define this phenomenon will include Chromatin immuno-precipitation 
(ChIP) analysis to evaluate histone modifications at the locus. We are also generating a “tunable” 
construct with drug-inducible promoters at Slc15a2 in F9 cells. These experiments will further 
elucidate the precise roles played by transcriptional interference and RNA interference in the 
disruption of Slc15a2 expression and function.  
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A similar disruption of MCC expression was recently found to be a result of three 
intronic novel TE integrants
5
. Our analysis of Complete Genomics whole genome data found that 
the L1-beta was present in 9% of the samples, the L1-alpha in 21% and the Alu element in 2% - 
indicating that at least one of these TEs is present in over 30% of the samples available. 
Moreover, TE polymorphisms present at high allele frequencies largely would not be expected to 
result in a significant gene disruption in essential tumor suppressor genes in the human genome, 
as was reported
3
. Furthermore, this down-regulation of MCC was indicated to be linked to liver 
cancer in the human population
5
. Because over 30% of the human population does not develop 
liver cancer as a result of the reported TE-mediated disruption of MCC, we were critical of the 
finding.  
Nonetheless, we studied this locus to understand whether the putative TE-mediated 
disruption actually occurs at MCC and to develop a system in which similar mechanism studies 
can be conducted. We first obtained 10 human lymphoblastoid cell lines and 22 liver cancer 
samples to confirm the presence or absence of each of the three TEs via a transposon-junction 
PCR assay. Next, we checked relative expression of the gene to correlate the presence of one of 
the reported TEs with down-regulation. And we anticipated, in our preliminary qRT-PCR 
analysis of 10 human lymphoblastoid cell lines and 22 liver cancer samples, variable expression 
levels of MCC were not associated with the presence of one or none of the intronic TEs.  
We recognize that in order to confirm our results, more samples are needed to achieve 
biological and statistical significance. However, this analysis corroborates our hypothesis that 
TE-mediated down-regulation may not occur at the MCC locus in humans. In their initial report 
of the phenomenon, the Faulkner group may have simply found the few samples in which the 
presence of the TE could be related to reduction in MCC expression in liver cancer samples. 
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However, our analysis did not confirm their result in studying additional samples. We conclude 
that TE-mediated disruption largely does not occur at MCC. 
Previous reports have shown the potency of transposons to result in gene disruption 
within the genome. Our own studies at both loci in different organisms, Slc15a2 in mice and 
MCC in humans, reveal the importance of a case-by-case analysis to identify novel instances of 
TE-mediated gene disruptions. These results provide insights into the conditions in which 
transposons are capable of initiating transcriptional instability and potentially leading to disease. 
Known examples of where TE insertions have induced a disease phenotype include the well-
documented A
vy
 gene in mice, in which IAP integration induced overexpression of the A gene, 
leading to obesity and type II diabetes
6
. Our own analysis of Slc15a2 proposes a novel model of 
transcriptional regulation by antisense transcripts initiated by new TE integrations (Figure 14). 
This field of research remains largely unexplored and to the best of our knowledge, Slc15a2 
could become one of the well-defined genes at which this mechanism of disruption in gene 
transcription and function occurs.  
Due to the prevalence of transposons within the mammalian genome and potency of 
various TE integrants to induce genetic instability, a careful analysis must be undertaken to 
determine how changes in gene expression result from new TE integrations, and then to follow 
up on well-documented cases to determine the underlying molecular mechanisms.  
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